( September 4, 2025, 10:27 AM EDT) -- PHILADELPHIA — End-payer plaintiffs (EPPs) in the generic drug pricing antitrust multidistrict litigation pending in a Pennsylvania federal court on Sept. 3 moved for preliminary approval of a settlement for up to $200 million with two manufacturers who allegedly conspired with others to artificially inflate the cost of prescription medications....